[{"NetIncomeLoss_1_Q2_USD":-12962000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":51904701.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":7013000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":3186000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.881,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.877,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-155000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":7395000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.011,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.011,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":15563000.0,"Depreciation_2_Q2_USD":500000.0,"Depreciation_1_Q2_USD":300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":3192000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":101000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":47000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1684000.0,"AssetsCurrent_0_Q2_USD":133346000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7314814.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7314814.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1635000.0,"CommonStockSharesIssued_0_Q2_shares":48146308.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":126466000.0,"Assets_0_Q2_USD":139672000.0,"ShareBasedCompensation_2_Q2_USD":3865000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3027000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":6.21,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1004000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":51483709.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":282000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3668000.0,"MarketableSecuritiesCurrent_0_Q2_USD":102593000.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":3793706.0,"ResearchAndDevelopmentExpense_2_Q2_USD":18627000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":9341000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":5.86,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":5964000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-24000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":51483709.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":51904701.0,"PrepaidExpenseCurrent_0_Q2_USD":3456000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":48000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":745000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":126451000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":11017000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":1000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":53500000.0,"OtherAssetsCurrent_0_Q2_USD":915000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-25974000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-12977000.0,"OtherAssetsNoncurrent_0_Q2_USD":282000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":26382000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3842000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":281973000.0,"Liabilities_0_Q2_USD":9786000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":6000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-2000.0,"OperatingLeaseLiability_0_Q2_USD":4960000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"GeneralAndAdministrativeExpense_2_Q2_USD":7430000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":775000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":21000.0,"OperatingIncomeLoss_2_Q2_USD":-26057000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":37913000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3200000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-18000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-15000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1937000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-24000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-13000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-21402000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":126466000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1588000.0,"LiabilitiesCurrent_0_Q2_USD":5944000.0,"AccountsPayableCurrent_0_Q2_USD":1633000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":26382000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":344000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.871,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.871,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":102000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.005,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.01,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":24543.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"OperatingLeasePayments_2_Q2_USD":504000.0,"OperatingLeasePayments_1_Q2_USD":259000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":16000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3017000.0,"NetIncomeLoss_2_Q2_USD":-25956000.0,"CommonStockSharesOutstanding_0_Q2_shares":48146308.0,"CommonStockSharesAuthorized_0_Q2_shares":125000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":5154000.0,"VariableLeaseCost_1_Q2_USD":180000.0,"OperatingIncomeLoss_1_Q2_USD":-13009000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":66000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.49,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.24,"OperatingLeaseCost_2_Q2_USD":550000.0,"OperatingLeaseCost_1_Q2_USD":275000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":139672000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":931000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3865000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1937000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":344717.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":6217000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1118000.0,"OperatingExpenses_2_Q2_USD":26057000.0,"OperatingExpenses_1_Q2_USD":13009000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.5,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.25,"ProfitLoss_2_Q2_USD":-25956000.0,"OtherLiabilitiesCurrent_0_Q2_USD":7000.0,"StockholdersEquity_0_Q2_USD":129886000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":24000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":126451000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1045000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":7311862.0,"VariableLeaseCost_2_Q2_USD":374000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-151980000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":202000.0,"Ticker":"KZR","CIK":"1645666","name":"KEZAR LIFE SCIENCES, INC.","OfficialName":"Kezar Life Sciences Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"829139908.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210812"}]